Page 77 - Lipids News Today

The Philippines needs to ramp up its investments on school infrastructure, as the country continues to lag behind, and the widening gap is impacting learning outcome among students.

Researchers discuss the use of the highly efficient CRISPR/Cas technologies to identify viral genome sequences for biosafety purposes.

Where are the biggest cardiovascular benefits for your patients with type 2 diabetes? Host Silvio Inzucchi and cardiologist Mikhail Kosiborod reveal winning strategies -- for managing much more than just type 2 diabetes.

Although dual antiplatelet therapy using cilostazol is associated with a lower risk of recurrent stroke in men, it has no significant benefit for women, a sub-analysis of CSPS.com results suggests.

A new method of directly measuring Lp(a) has been shown to allow more accurate values for LDL cholesterol to be calculated in some patients, which could alter their chosen treatment strategy.

A year of high-intensity interval training appeared to benefit obese middle-aged adults at high risk for heart failure, but omega-3 supplements didnt affect cardiac biomarkers, in a single-center study.

"Among Hispanic/Latino youth, no study, to our knowledge has evaluated food insecuritys role in metabolic syndrome and metabolic syndrome–relevant cardiometabolic markers in this population."

Sousa is heralded as a giant in the field of interventional cardiology, a man who led the world in innovative technologies and was the first to perform procedures now taken for granted.

Serious mental illnesses like bipolar disorder and schizophrenia are associated with a higher risk of cardiovascular disease, with even greater risk seen among younger age groups.

Recommendations to help doctors distinguish between true side effects of statins and those arising from patients’ expectations launched by international expert group.